| |
Business address:
Avontec GmbH • Fraunhofer Str. 15A • 82152 München
| Education: | ||
| 1975 - 1976 | Chemistry, University of Hannover | |
| 1979 - 1986 | M.D., Hannover Medical School | |
| Postgraduate Training: | ||
| 1986 - 1988 | Pharmacology, University of Hamburg | |
| 1988 - 1992 | Internal Medicine and Cardiology, Hannover Medical School | |
| 1992 -1994 | Research
Fellow Falk Cardiovascular Research Center, Stanford University (Cardiovascular gene transfer) |
|
| 1994 - 1995 | Fellow, Division of Cardiovascular Medicine, Stanford University | |
| 1995 - 1996 | Instructor
in Medicine, Stanford University - Supervisor, Gene Transfer Group (Falk CVRC) |
|
| 1996 - 1998 | Cardiology, Hannover Medical School | |
| 1997 | Habilitation, Experimental Cardiology | |
| 1998 | Habilitation, Internal Medicine | |
| since 2002 | External faculty member of Hannover Medical School | |
| Specialty Certification: | ||
| 1998 | German Board of Internal Medicine | |
| Industry Positions: | ||
| 1998 - 2001 | Medical
Director and Vice President Clinical Development Cardion AG, Erkrath Program Head: Restenosis gene therapy |
|
| 2001 - 2002 | Chief Scientific Officer, ARTISS GmbH, Hannover | |
| since Jan 2003 | Chief Scientific Officer, AVONTEC GmbH, München | |